TWC
BRTX icon

TD Waterhouse Canada’s BioRestorative Therapies BRTX Stock Holding History

TD Waterhouse Canada’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Hold
3
– – ﹤0.01% 2399
2026
Q1 		$1 Hold
3
– – ﹤0.01% 2301
2025
Q4 		$3 Hold
3
– – ﹤0.01% 2030
2025
Q3 		$4 Hold
3
– – ﹤0.01% 2055
2025
Q2 		$5 Hold
3
– – ﹤0.01% 1982
2025
Q1 		$5 Buy
3
+1
+50% +$2 ﹤0.01% 1936
2024
Q4 		$3 Hold
2
– – ﹤0.01% 1957
2024
Q3 		$3 Buy
+2
New +$3 ﹤0.01% 1898

Other funds holding BRTX

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KFGK
Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return

TD Waterhouse Canada's BRTX Position: Q2 2026 in Review

TD Waterhouse Canada held its BioRestorative Therapies (BRTX) position steady in Q2 2026 at 3 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #2399.

TD Waterhouse Canada first reported a position in BRTX in Q3 2024 and has held it in 8 quarters since. The position peaked at $5 in Q2 2025. 21 funds tracked by Wall St. Rank hold BRTX as of Q2 2026.

  • TD Waterhouse Canada held 3 shares of BioRestorative Therapies worth $1 as of Q2 2026.
  • TD Waterhouse Canada left its BioRestorative Therapies share count unchanged in Q2 2026.
  • BioRestorative Therapies made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2399 holding.
  • TD Waterhouse Canada first reported a position in BioRestorative Therapies in Q3 2024 and has held it in 8 quarters since.
  • TD Waterhouse Canada's BioRestorative Therapies position peaked at $5 in Q2 2025.
  • 21 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.